November 1, 2024 | COVID, Patient Retention, clinical trials, influenza, patient recruitment
The Northern Hemisphere flu season is fast approaching, bringing with it a multitude of challenges for respiratory clinical trials. The exact dates of the flu season in the Northern Hemisphere vary every year, but it is usually from October to May, with peaks of activity between December and May.

Is your study prepared to recruit and retain patients effectively? In our, “Key Considerations for Patient Recruitment and Retention – Part #1,” we explore essential strategies to ensure your trial stands out.
🔍 Highlights:
⭐️Patient Awareness: Learn how to increase trial visibility and engage the local community.
⭐️Community Outreach: Discover effective methods to reach potential participants.
⭐️Referral Networks: Optimize your network to maximize patient recruitment.
Read the full blog now and get ahead this flu season!👉 https://bit.ly/3WVnVEm
This content was provided by Innovative Trials
Company Details
Latest Content from Innovative Trials
Patient recruitment is arguably one of the most important aspects of a clinical trial. Without enough participants, trials will inevitably fail, meaning potentially effective therapies will not be brought to…
We have seen a growing focus on patient diversity in clinical trials in recent years, but the COVID-19 vaccine trials in particular have highlighted the importance of achieving diverse patient…
UK-based patient recruitment company announces its annual charity partnership in support of multiple sclerosis
Innovative Trials and Parexel invite you to attend the live webinar
The patient recruitment organisation has been shortlisted in the Inspiring Hertfordshire awards
Kate Shaw, Founder & CEO of the leading patient recruitment organisation based in Letchworth (UK), on the current Russia-Ukraine situation.
A key requirement for clinical trials is to understand the effect of potential treatments on the patient populations that will benefit most. Despite this, many studies find diverse patient recruitment…
Phase IIa Moderate to Severe Hidradenitis Suppurativa Case Study
In the latest blog post, Innovative Trials’ Equality & Diversity committee focuses on eating disorders
Innovative Trials, Pfizer and Parexel invite you to attend the live webinar
